Skip to main content
. 2020 May 4;13:42. doi: 10.1186/s13045-020-00873-7

Table 3.

Results of main clinical outcomes after CAR-T

Group 1-year cumulative incidence of relapse (%) 2-year cumulative incidence of relapse (%) 1-year LFS (%) 2-year LFS (%) 1-year OS (%) 2-year OS (%)
Non-transplant 55.3 67.2 44.7 32.8 59.1 36.4
MRD+ 38.2 65.8 55.2 27.6 62.7 62.7
MRD− 8.4 17.3 91.6 76.1 94.3 83.3
P between non-transplant and MRD+ 0.139 0.305 0.231
P between non-transplant and MRD− < 0.001 < 0.001 < 0.001
P between MRD+ and MRD− 0.006 0.007 0.069